BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15605987)

  • 1. Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas.
    Neder L; Marie SK; Carlotti CG; Gabbai AA; Rosemberg S; Malheiros SM; Siqueira RP; Oba-Shinjo SM; Uno M; Aguiar PH; Miura F; Chammas R; Colli BO; Silva WA; Zago MA
    Brain Pathol; 2004 Oct; 14(4):399-405. PubMed ID: 15605987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of immune defense genes in pilocytic astrocytomas.
    Huang H; Hara A; Homma T; Yonekawa Y; Ohgaki H
    J Neuropathol Exp Neurol; 2005 Oct; 64(10):891-901. PubMed ID: 16215461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profile of tumors with oligodendroglial morphology: Clinical relevance.
    Geevar T; Pai R; Chacko G; Malepathi K; Patel B; John J; Chacko AG; Balakrishnan R; John S
    Neurol India; 2018; 66(6):1726-1731. PubMed ID: 30504574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
    Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
    Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration.
    Camby I; Belot N; Rorive S; Lefranc F; Maurage CA; Lahm H; Kaltner H; Hadari Y; Ruchoux MM; Brotchi J; Zick Y; Salmon I; Gabius HJ; Kiss R
    Brain Pathol; 2001 Jan; 11(1):12-26. PubMed ID: 11145198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
    Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
    Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma.
    Barresi V; Mondello S; Branca G; Rajan TS; Vitarelli E; Tuccari G
    Hum Pathol; 2015 Feb; 46(2):231-8. PubMed ID: 25476123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of ABCA2' a possible molecular marker for oligodendrogliomas.
    Soichi O; Masanori N; Hideo T; Kazunori A; Nobuya I; Jun-ichi K
    Neurosurgery; 2007 Apr; 60(4):707-14; discussion 714. PubMed ID: 17415208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas.
    Zhuang Z; Qi M; Li J; Okamoto H; Xu DS; Iyer RR; Lu J; Yang C; Weil RJ; Vortmeyer A; Lonser RR
    J Neurosurg; 2011 Oct; 115(4):789-95. PubMed ID: 21682567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3: a useful biomarker for differential diagnosis of brain tumors.
    Park SH; Min HS; Kim B; Myung J; Paek SH
    Neuropathology; 2008 Oct; 28(5):497-506. PubMed ID: 18384511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas.
    Riemenschneider MJ; Koy TH; Reifenberger G
    Acta Neuropathol; 2004 Mar; 107(3):277-82. PubMed ID: 14730454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.
    Nutt CL; Betensky RA; Brower MA; Batchelor TT; Louis DN; Stemmer-Rachamimov AO
    Clin Cancer Res; 2005 Mar; 11(6):2258-64. PubMed ID: 15788675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of interleukin-1beta mRNA and protein in human gliomas assessed by RT-PCR and immunohistochemistry.
    Sasaki A; Tamura M; Hasegawa M; Ishiuchi S; Hirato J; Nakazato Y
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):653-63. PubMed ID: 9690669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
    Capper D; Reuss D; Schittenhelm J; Hartmann C; Bremer J; Sahm F; Harter PN; Jeibmann A; von Deimling A
    Acta Neuropathol; 2011 Feb; 121(2):241-52. PubMed ID: 21069360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group A1 expression correlates with the histological grade of human glial tumors.
    Donato G; Martinez Hoyos J; Amorosi A; Maltese L; Lavano A; Volpentesta G; Signorelli F; Pentimalli F; Pallante P; Ferraro G; Tucci L; Signorelli CD; Viglietto G; Fusco A
    Oncol Rep; 2004 Jun; 11(6):1209-13. PubMed ID: 15138557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
    Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
    J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
    Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
    J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
    Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
    J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.